OOIR: Observatory of International Research

Papers

(The median citation count of Oncology Reports is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)

Article	Citations
Molecular mechanisms of platinum‑based chemotherapy resistance in ovarian cancer (Review)	101
Chlorogenic acid induces apoptosis, inhibits metastasis and improves antitumor immunity in breast cancer via the NF‑κB signaling pathway	86
Endoplasmic reticulum stress, cell death and tumor: Association between endoplasmic reticulum stress and the apoptosis pathway in tumors (Review)	62
CREB stimulates GPX4 transcription to inhibit ferroptosis in lung adenocarcinoma	61
Dihydroartemisinin triggers ferroptosis in primary liver cancer cells by promoting and unfolded protein response‑induced upregulation of CHAC1 expression	56
HSP90 inhibitors and cancer: Prospects for use in targeted therapies (Review)	53
KRT7 promotes epithelial‑mesenchymal transition in ovarian cancer via the TGF‑β/Smad2/3 signaling pathway	45
Evaluating the biological functions of the prognostic genes identified by the Pathology Atlas in bladder cancer	44
TELO2 induced progression of colorectal cancer by binding with RICTOR through mTORC2	43
The role of interaction between autophagy and apoptosis in tumorigenesis (Review)	42
Critical immunosuppressive effect of MDSC‑derived exosomes in the tumor microenvironment	40
Molecular features and gene expression signature of metastatic colorectal cancer (Review)	38
CD155/TIGIT, a novel immune checkpoint in human cancers (Review)	38
Hormone therapy for ovarian cancer: Emphasis on mechanisms and applications (Review)	33
Exosomal miR‑663b exposed to TGF‑β1 promotes cervical cancer metastasis and epithelial‑mesenchymal transition by targeting MGAT3	31
IGFBP2 in cancer: Pathological role and clinical significance (Review)	31
METTL3‑mediated m6A modification of Bcl‑2 mRNA promotes non‑small cell lung cancer progression	31
Inhibition of the VEGF signaling pathway attenuates tumor‑associated macrophage activity in liver cancer	31
Anticancer effects and potential mechanisms of ginsenoside Rh2 in various cancer types (Review)	30
UHRF1 regulates the transcriptional repressor HBP1 through MIF in T acute lymphoblastic leukemia	29
Modulating epigenetic modifications for cancer therapy (Review)	29
Regulation of ferroptosis by non‑coding RNAs in the development and treatment of cancer (Review)	29
Role of chemokines in hepatocellular carcinoma (Review)	28
Kaempferol exhibits a synergistic effect with doxorubicin to inhibit proliferation, migration, and invasion of liver cancer	27
Exosome-mediated radiosensitizing effect on neighboring cancer cells via increase in intracellular levels of reactive oxygen species	27

Triptolide inhibits JAK2/STAT3 signaling and induces lethal autophagy through ROS generation in cisplatin‑resistant SKOV3/DDP ovarian cancer cells	27
Erb‑B2 Receptor Tyrosine Kinase 2 is negatively regulated by the p53‑responsive microRNA‑3184‑5p in cervical cancer cells	27
ESM1/HIF‑1α pathway modulates chronic intermittent hypoxia‑induced non‑small‑cell lung cancer proliferation, stemness and epithelial‑mesenchymal transition	26
Curcumin promotes cell cycle arrest and apoptosis of acute myeloid leukemia cells by inactivating AKT	26
IFNγ enhances ferroptosis by increasing JAK‑STAT pathway activation to suppress SLCA711 expression in adrenocortical carcinoma	25
miRNA‑199b‑3p suppresses growth and progression of ovarian cancer via the CHK1/E‑cadherin/EMT signaling pathway by targeting ZEB1	25
Ferroptosis inducer erastin downregulates androgen receptor and its splice variants in castration‑resistant prostate cancer	25
HDAC inhibitors suppress the proliferation, migration and invasiveness of human head and neck squamous cell carcinoma cells via p63‑mediated tight junction molecules and p21‑mediated growth arrest	24
Platelet‑derived growth factor‑BB mediates pancreatic cancer malignancy via regulation of the Hippo/Yes‑associated protein signaling pathway	24
Inhibition of LDHA suppresses cell proliferation and increases mitochondrial apoptosis via the JNK signaling pathway in cervical cancer cells	24
Metastatic pancreatic cancer: Mechanisms and detection (Review)	24
Catechol enhances chemo‑ and radio‑sensitivity by targeting AMPK/Hippo signaling in pancreatic cancer cells	24
Bile reflux and hypopharyngeal cancer (Review)	23
Diagnostic and therapeutic role of microRNAs in oral cancer (Review)	23
Bendamustine: a review of pharmacology, clinical use and immunological effects (Review)	23
CDCA5 promotes the progression of prostate cancer by affecting the ERK signalling pathway	22
lncRNA FOXP4‑AS1 predicts poor prognosis and accelerates the progression of mantle cell lymphoma through the miR‑423‑5p/NACC1 pathway	22
Anti‑HER3 monoclonal antibody exerts antitumor activity in a mouse model of colorectal adenocarcinoma	22
Interactions between long non‑coding RNAs and RNA‑binding proteins in cancer (Review)	22
Mechanism of tumor‑derived extracellular vesicles in regulating renal cell carcinoma progression by the delivery of MALAT1	21
lncRNA CASC9 sponges miR‑758‑3p to promote proliferation and EMT in bladder cancer by upregulating TGF‑β2	21
Celastrol attenuates the inflammatory response by inhibiting IL‑1β expression in triple‑negative breast cancer cells	21
Role of reactive oxygen species in tumors based on the ‘seed and soil’ theory: A complex interaction (Review)	21
Hsa_circ_0016760 exacerbates the malignant development of non‑small cell lung cancer by sponging miR‑145‑5p/FGF5	21
5‑Fluorouracil and capecitabine therapies for the treatment of colorectal cancer (Review)	21
miR‑454‑3p inhibits non‑small cell lung cancer cell proliferation and metastasis by targeting TGFB2	21
Multifunctional nanoparticle PEG‑Ce6‑Gd for MRI‑guided photodynamic therapy	21
Chronic stress promotes glioma cell proliferation via the PI3K/Akt signaling pathway	20
PD‑L1/PD‑1 blockade in breast cancer: The immunotherapy era (Review)	20
Exosomal connexin 43 regulates the resistance of glioma cells to temozolomide	20
Downregulation of triggering receptor expressed on myeloid cells 1 inhibits invasion and migration of liver cancer cells by mediating macrophage polarization	19
Long non‑coding RNA PCED1B‑AS1 promotes pancreatic ductal adenocarcinoma progression by regulating the miR‑411‑3p/HIF‑1α axis	19
Lycorine inhibits cell proliferation, migration and invasion, and primarily exerts in vitro cytostatic effects in human colorectal cancer via activating the ROS/p38 and AKT signaling pathways	19
Escin inhibits angiogenesis by suppressing interleukin‑8 and vascular endothelial growth factor production by blocking nuclear factor‑κB activation in pancreatic cancer cell lines	19
An anti‑TROP2 monoclonal antibody TrMab‑6 exerts antitumor activity in breast cancer mouse xenograft models	18
Knockdown of ZEB1 reverses cancer stem cell properties in prostate cancer cells	18
ELOVL2 promotes cancer progression by inhibiting cell apoptosis in renal cell carcinoma	18
Combination of resveratrol and green tea epigallocatechin gallate induces synergistic apoptosis and inhibits tumor growth in vivo in head and neck cancer models	18
Progesterone suppresses the progression of colonic carcinoma by increasing the activity of the GADD45α/JNK/c‑Jun signalling pathway	18
Galectin‑9 suppresses the tumor growth of colon cancer in vitro and in vivo	18
Vanillin downregulates NNMT and attenuates NNMT‑related resistance to 5‑fluorouracil via ROS‑induced cell apoptosis in colorectal cancer cells	18
Long non‑coding RNA MIR4435‑2HG promotes the progression of head and neck squamous cell carcinoma by regulating the miR‑383‑5p/RBM3 axis	18
circHIPK3 promotes proliferation and migration and invasion via regulation of miR‑637/HDAC4 signaling in osteosarcoma cells	18
Advances in metformin‑based metabolic therapy for non‑small cell lung cancer (Review)	18
Polyphyllin VII induces mitochondrial apoptosis by regulating the PP2A/AKT/DRP1 signaling axis in human ovarian cancer	18
Polyphyllin VII induces apoptosis and autophagy via mediating H2O2 levels and the JNK pathway in human osteosarcoma U2OS cells	17
A randomized phase III trial of personalized peptide vaccination for castration‑resistant prostate cancer progressing after docetaxel	17
lncRNA DUXAP8 inhibits papillary thyroid carcinoma cell apoptosis via sponging the miR‑20b‑5p/SOS1 axis	17
Long non‑coding RNA AC245100.4 promotes prostate cancer tumorigenesis via the microRNA‑145‑5p/RBBP5 axis	17
Roles of the H19/microRNA‑675 axis in the proliferation and epithelial‑mesenchymal transition of human cutaneous squamous cell carcinoma cells	17

Curcumol inhibits the malignant progression of prostate cancer and regulates the PDK1/AKT/mTOR pathway by targeting miR‑9	17
Role of MRI‑based radiomics in locally advanced rectal cancer (Review)	17
MMP11 promotes the proliferation and progression of breast cancer through stabilizing Smad2 protein	17
Roles of circRNAs in cancer chemoresistance (Review)	17
Therapeutic potential of endogenous hydrogen sulfide inhibition in breast cancer (Review)	17
Circadian clock protein CRY1 prevents paclitaxel‑induced senescence of bladder cancer cells by promoting p53 degradation	16
Schisandrin B inhibits epithelial‑mesenchymal transition and stemness of large‑cell lung cancer cells and tumorigenesis in xenografts via inhibiting the NF‑κB and p38 MAPK signaling pathways	16
LOXL1‑AS1 promotes thymoma and thymic carcinoma progression by regulating miR‑525‑5p‑HSPA9	16
Circular RNA hsa_circ_0001666 sponges miR‑330‑5p, miR‑193a‑5p and miR‑326, and promotes papillary thyroid carcinoma progression via upregulation of ETV4	16
FOXD3‑AS1/miR‑128‑3p/LIMK1 axis regulates cervical cancer progression	16
Diosmin in combination with naringenin enhances apoptosis in colon cancer cells	16
DDX41 regulates the expression and alternative splicing of genes involved in tumorigenesis and immune response	16
Natural killer cell‑based immunotherapy for lung cancer: Challenges and perspectives (Review)	16
HORMAD1 promotes docetaxel resistance in triple negative breast cancer by enhancing DNA damage tolerance	16
Abnormal function of telomere protein TRF2 induces cell mutation and the effects of environmental tumor‑promoting factors (Review)	16
MicroRNA‑642a‑5p inhibits colon cancer cell migration and invasion by targeting collagen type I α1	16
Regulatory functions of miR‑200b‑3p in tumor development (Review)	15
Mechanism of acquired 5FU resistance and strategy for overcoming 5FU resistance focusing on 5FU metabolism in colon cancer cell lines	15
Phenethyl isothiocyanate reduces breast cancer stem cell-like properties by epigenetic reactivation of CDH1	15
lncRNA PART1, manipulated by transcriptional factor FOXP2, suppresses proliferation and invasion in ESCC by regulating the miR‑18a‑5p/SOX6 signaling axis	15
Melatonin sensitizes esophageal cancer cells to 5‑fluorouracil via promotion of apoptosis by regulating EZH2 expression	15
Dual STAT‑3 and IL‑6R inhibition with stattic and tocilizumab decreases migration, invasion and proliferation of prostate cancer cells by targeting the IL‑6/IL‑6R/STAT‑3 axis	15
Development of patient‑derived tumor organoids and a drug testing model for renal cell carcinoma	15
The role of immunotherapy and molecular‑targeted therapy in the treatment of melanoma (Review)	15
Semaphorin 4D is a potential biomarker in pediatric leukemia and promotes leukemogenesis by activating PI3K/AKT and ERK signaling pathways	15
Research progress of anti-glioma chemotherapeutic drugs (Review)	14
Exosomes derived from retinoblastoma cells enhance tumour deterioration by infiltrating the microenvironment	14
Phlorizin from sweet tea inhibits the progress of esophageal cancer by antagonizing the JAK2/STAT3 signaling pathway	14
Glucose transporter‑1 inhibition overcomes imatinib resistance in gastrointestinal stromal tumor cells	14
Blue light irradiation inhibits the growth of colon cancer and activation of cancer‑associated fibroblasts	14
VSP‑17 suppresses the migration and invasion of triple‑negative breast cancer cells through inhibition of the EMT process via the PPARγ/AMPK signaling pathway	14
Anticancer effects of natural phytochemicals in anaplastic thyroid cancer (Review)	14
PD‑L1 and IDO‑1 expression in undifferentiated pleomorphic sarcoma: The associations with tumor infiltrating lymphocytes, dMMR and HLA class I	14
Long non‑coding RNA NEAT1 regulates glioma cell proliferation and apoptosis by competitively binding to microRNA‑324‑5p and upregulating KCTD20 expression	14
Tumor microenvironment manipulates chemoresistance in ovarian cancer (Review)	14
Tissue factor pathway inhibitor‑2 is specifically expressed in ovarian clear cell carcinoma tissues in the nucleus, cytoplasm and extracellular matrix	14
Long non‑coding RNA ST8SIA6‑AS1 promotes the migration and invasion of hypoxia‑treated hepatocellular carcinoma cells through the miR‑338/MEPCE axis	14
Novel quinazolinone MJ‑33 induces AKT/mTOR‑mediated autophagy‑associated apoptosis in 5FU‑resistant colorectal cancer cells	14
CDK4 overexpression is a predictive biomarker for resistance to conventional chemotherapy in patients with osteosarcoma	14
Role of SIRT1/AMPK signaling in the proliferation, migration and invasion of renal cell carcinoma cells	14
Autophagy inhibition and microRNA‑199a‑5p upregulation in paclitaxel‑resistant A549/T lung cancer cells	14
MicroRNA‑34a‑5p serves as a tumor suppressor by regulating the cell motility of bladder cancer cells through matrix metalloproteinase‑2 silencing	14
HMGB1 promotes the development of castration‑resistant prostate cancer by regulating androgen receptor activation	13
Identification of in vitro and in vivo oncolytic effect in colorectal cancer cells by Orf virus strain NA1/11	13
Methylation of the miR‑29b‑3p promoter contributes to angiogenesis, invasion, and migration in pancreatic cancer	13
LncRNA CDKN2B‑AS1 sponges miR‑28‑5p to regulate proliferation and inhibit apoptosis in colorectal cancer	13
GBP2 promotes clear cell renal cell carcinoma progression through immune infiltration and regulation of PD‑L1 expression via STAT1 signaling	13
lncRNA TINCR attenuates the proliferation and invasion, and enhances the apoptosis of cutaneous malignant melanoma cells by regulating the miR‑424‑5p/LATS1 axis	13
Circ_0000003 regulates glutamine metabolism and tumor progression of tongue squamous cell carcinoma via the miR‑330‑3p/GLS axis	13
Metformin inhibits mTOR and c-Myc by decreasing YAP protein expression in OSCC cells	13
Glutathione peroxidase 2 overexpression promotes malignant progression and cisplatin resistance of KRAS‑mutated lung cancer cells	13
Leptin stimulates migration and invasion and maintains cancer stem‑like properties in gastric cancer cells	13
lncRNA MEG3 inhibits pituitary tumor development by participating in cell proliferation, apoptosis and EMT processes	13
BCAT1 overexpression regulates proliferation and c‑Myc/GLUT1 signaling in head and neck squamous cell carcinoma	13
Signs of carcinogenicity induced by parathion, malathion, and estrogen in human breast epithelial cells (Review)	13
Combining selective inhibitors of nuclear export (SINEs) with chimeric antigen receptor (CAR) T cells for CD19‑positive malignancies	13
The PTBP1‑NCOA4 axis promotes ferroptosis in liver cancer cells	13
Combination treatment with VPA and MSCs‑TRAIL could increase anti‑tumor effects against intracranial glioma	13
Knockdown of circNRIP1 sensitizes colorectal cancer to 5‑FU via sponging miR‑532‑3p	13
Circular RNA TADA2A promotes proliferation and migration via modulating of miR‑638/KIAA0101 signal in non‑small cell lung cancer	13
Schisandrin B suppresses osteosarcoma lung metastasisin vivoby inhibiting the activation of the Wnt/β‑catenin and PI3K/Akt signaling pathways	13
Upregulation of TRIP13 promotes the malignant progression of lung cancer via the EMT pathway	13
Hypoxia induces radioresistance, epithelial‑mesenchymal transition, cancer stem cell‑like phenotype and changes in genes possessing multiple biological functions in head and neck squamous cell carcino	13
SIRT1 and gynecological malignancies (Review)	13
An unexpected link: The role of mammary and gut microbiota on breast cancer development and management (Review)	12
Tumorigenic effect of TERT and its potential therapeutic target in NSCLC (Review)	12
Pinosylvin inhibits migration and invasion of nasopharyngeal carcinoma cancer cells via regulation of epithelial‑mesenchymal transition and inhibition of MMP‑2	12
Long non‑coding RNA AFAP1‑AS1 facilitates the growth and invasiveness of oral squamous cell carcinoma by regulating the miR‑145/HOXA1 axis	12
RORβ suppresses the stemness of gastric cancer cells by downregulating the activity of the Wnt signaling pathway	12
Dehydrocrenatidine extracted from Picrasma quassioides induces the apoptosis of nasopharyngeal carcinoma cells through the JNK and ERK signaling pathways	12
Acanthopanax senticosus Harms extract causes G0/G1 cell cycle arrest and autophagy via inhibition of Rubicon in human liver cancer cells	12
Plasma‑derived exosomal pyruvate kinase isoenzyme type M2 accelerates the proliferation and motility of oesophageal squamous cell carcinoma cells	12
Fangchinoline exerts antitumour activity by suppressing the EGFR‑PI3K/AKT signalling pathway in colon adenocarcinoma	12
Utility of flow cytometry and gene rearrangement analysis in tissue and blood of patients with suspected cutaneous T‑cell lymphoma	12
Emerging roles of circular RNAs in non‑small cell lung cancer (Review)	12
A guide through conventional and modern cancer treatment modalities: A specific focus on glioblastoma cancer therapy (Review)	12
Progression of melanoma is suppressed by targeting all transforming growth factor‑β isoforms with an Fc chimeric receptor	12
miR‑146b‑5p inhibits tumorigenesis and metastasis of gallbladder cancer by targeting Toll‑like receptor 4 via the nuclear factor‑κB pathway	12
Inhibition of GP130/STAT3 and EMT by combined bazedoxifene and paclitaxel treatment in ovarian cancer	12
lncRNA‑CASC15 promotes osteosarcoma proliferation and metastasis by regulating epithelial‑mesenchymal transition via the Wnt/β‑catenin signaling pathway	12

Ginsenoside compound K exerts antitumour effects in renal cell carcinoma via regulation of ROS and lncRNA THOR	12
LINC00665 functions as a competitive endogenous RNA to regulate AGTR1 expression by sponging miR‑34a‑5p in glioma	12
LncRNA GATA3‑AS1‑miR‑30b‑5p‑Tex10 axis modulates tumorigenesis in pancreatic cancer	12
Long non‑coding RNA FER1L4 inhibits cell proliferation and promotes cell apoptosis via the PTEN/AKT/p53 signaling pathway in lung cancer	11
Effects of m6A modifications on signaling pathways in human cancer (Review)	11
Egr‑1 inhibits colon cancer cell proliferation, migration and invasion via regulating CDKL1 at the transcriptional level	11
Stomatin‑like protein 2 induces metastasis by regulating the expression of a rate‑limiting enzyme of the hexosamine biosynthetic pathway in pancreatic cancer	11
Oncolytic adenovirus: A tool for reversing the tumor microenvironment and promoting cancer treatment (Review)	11
HPV E7 affects the function of cervical cancer cells via the TAL1/lnc‑EBIC/KLHDC7B axis	11
β‑glucan vaccine adjuvant approach for cancer treatment through immune enhancement (B‑VACCIEN) in specific immunocompromised populations (Review)	11
Long non‑coding RNA H19 regulates LASP1 expression in osteosarcoma by competitively binding to miR‑29a‑3p	11
LINC01816 promotes the migration, invasion and epithelial‑mesenchymal transition of thyroid carcinoma cells by sponging miR‑34c‑5p and regulating CRABP2 expression levels	11
In vitro anticancer effects of alpelisib against PIK3CA‑mutated canine hemangiosarcoma cell lines	11
Berberine exerts its antineoplastic effects by reversing the Warburg effect via downregulation of the Akt/mTOR/GLUT1 signaling pathway	11
Bruton's agammaglobulinemia tyrosine kinase (Btk) regulates TPA‑induced breast cancer cell invasion via PLCγ2/PKCβ/NF‑κB/AP‑1‑dependent matrix metalloproteinase‑9 activation	11
Genetic deletion of Rnd3 suppresses apoptosis through NF‑κB signaling in the brain	11
Sensitizing TRAIL‑resistant A549 lung cancer cells and enhancing TRAIL‑induced apoptosis with the antidepressant amitriptyline	11
Long non‑coding RNA CASC19 promotes glioma progression by modulating the miR‑454‑3p/RAB5A axis and is associated with unfavorable MRI features	11
Combination of Huanglian Jiedu Decoction and erlotinib delays growth and improves sensitivity of EGFR‑mutated NSCLC cells in vitro and in vivo via STAT3/Bcl‑2 signaling	11
Dinaciclib inhibits the stemness of two subtypes of human breast cancer cells by targeting the FoxM1 and Hedgehog signaling pathway	10
BET inhibitors combined with chemotherapy synergistically inhibit the growth of NSCLC cells	10
circNSUN2 promotes the malignant biological behavior of colorectal cancer cells via the miR‑181a‑5p/ROCK2 axis	10
Dual inhibition of FOXM1 and its compensatory signaling pathway decreased the survival of ovarian cancer cells	10
Mesenchymal stem cells promote chemoresistance by activating autophagy in intrahepatic cholangiocarcinoma	10
Mechanisms and functions of long non‑coding RNAs in glioma (Review)	10
TMEM229A suppresses non‑small cell lung cancer progression via inactivating the ERK pathway	10
Antitumor effect of humanized anti‑tissue factor antibody‑drug conjugate in a model of peritoneal disseminated pancreatic cancer	10
Zinc finger protein 384 enhances colorectal cancer metastasis by upregulating MMP2	10
lncRNA MALAT1/miR‑26a/26b/ST8SIA4 axis mediates cell invasion and migration in breast cancer cell lines	10
Enhancement of cisplatin sensitivity in human breast cancer MCF-7 cell line through BiP and 14-3-3ζ co-knockdown	10
FGD5‑AS1 is an oncogenic lncRNA in pancreatic cancer and regulates the Wnt/β‑catenin signaling pathway via miR‑577	10
Dose adjustment for tyrosine kinase inhibitors in non‑small cell lung cancer patients with hepatic or renal function impairment (Review)	10
Matrine inhibits ovarian cancer cell viability and promotes apoptosis by regulating the ERK/JNK signaling pathway via p38MAPK	10
Enhanced CXCL12/CXCR4 signaling increases tumor progression in radiation‑resistant pancreatic cancer	10
CREB1 acts via the miR‑922/ARID2 axis to enhance malignant behavior of liver cancer cells	10
Mesenchymal stem cells induce tumor stroma formation and epithelial‑mesenchymal transition through SPARC expression in colorectal cancer	10
SPC25 promotes hepatocellular carcinoma metastasis via activating the FAK/PI3K/AKT signaling pathway through ITGB4	10
Differential MUC22 expression by epigenetic alterations in human lung squamous cell carcinoma and adenocarcinoma	10
ATR inhibitor AZD6738 increases the sensitivity of colorectal cancer cells to 5‑fluorouracil by inhibiting repair of DNA damage	10
Amine oxidase, copper containing 3 exerts anti‑mesenchymal transformation and enhances CD4⁺ T‑cell recruitment to prolong survival in lung cancer	10
Role of hypoxia‑inducible factor‑2α in lung cancer (Review)	10
New insights into Epstein‑Barr virus‑associated tumors: Exosomes (Review)	10
IL‑6 plays a crucial role in epithelial‑mesenchymal transition and pro‑metastasis induced by sorafenib in liver cancer	10
Apigenin inhibits renal cell carcinoma cell proliferation through G2/M phase cell cycle arrest	10
EGFR inhibition reverses epithelial‑mesenchymal transition, and decreases tamoxifen resistance via Snail and Twist downregulation in breast cancer cells	10
Roles of the SNHG7/microRNA‑9‑5p/DPP4 ceRNA network in the growth and ¹³¹I resistance of thyroid carcinoma cells through PI3K/Akt activation	10
Breast and prostate glands affected by environmental substances (Review)	10
Overview of serpin B9 and its roles in cancer (Review)	10
Overexpressed lncRNA FTX promotes the cell viability, proliferation, migration and invasion of renal cell carcinoma via FTX/miR‑4429/UBE2C axis	10
lncRNA HOTAIRM1 regulates cell proliferation and the metastasis of thyroid cancer by targeting Wnt10b	10
Cell‑cell fusion as an important mechanism of tumor metastasis (Review)	9
Safety and efficacy of anaplastic lymphoma kinase tyrosine kinase inhibitors in non‑small cell lung cancer (Review)	9
PIWI‑interacting RNA in cancer: Molecular mechanisms and possible clinical implications (Review)	9
Epigenetic therapy with chidamide alone or combined with 5‑azacitidine exerts antitumour effects on acute myeloid leukaemia cells in vitro	9
Hypochlorous acid selectively promotes toxicity and the expression of danger signals in human abdominal cancer cells	9
Regulators of epigenetic change in ferroptosis‑associated cancer (Review)	9
Acidic microenvironment induction of interleukin-8 expression and matrix metalloproteinase-2/-9 activation via acid-sensing ion channel 1 promotes breast cancer cell progression	9
S100A8 promotes chemoresistance via augmenting autophagy in B‑cell lymphoma cells	9
Next‑generation sequencing analysis reveals that MTH‑3, a novel curcuminoid derivative, suppresses the invasion of MDA‑MB‑231 triple‑negative breast adenocarcinoma cells	9
Melanoma metastasis: What role does melanin play? (Review)	9
Berberine enhances gemcitabine‑induced cytotoxicity in bladder cancer by downregulating Rad51 expression through inactivating the PI3K/Akt pathway	9
LRPPRC contributes to the cisplatin resistance of lung cancer cells by regulating MDR1 expression	9
Expression of immune response biomarkers (PD‑L1, p16, CD3+ and CD8+ TILs) in recurrent head and neck squamous cell carcinoma within previously irradiated areas	9
Circular RNA circBLNK promotes osteosarcoma progression and inhibits ferroptosis in osteosarcoma cells by sponging miR‑188‑3p and regulating GPX4 expression	9
Upregulation of SKA3 enhances cell proliferation and correlates with poor prognosis in hepatocellular carcinoma	9
AMOTL2‑knockdown promotes the proliferation, migration and invasion of glioma by regulating β‑catenin nuclear localization	9
SOX12 contributes to the activation of the JAK2/STAT3 pathway and malignant transformation of esophageal squamous cell carcinoma	9
HOXA‑AS3 induces tumor progression through the epithelial‑mesenchymal transition pathway in epithelial ovarian cancer	9
Potential roles of exosome non‑coding RNAs in cancer chemoresistance (Review)	9
Expression and role of fibroblast activation protein α in acute myeloid leukemia	9
Garcinol inhibits the proliferation of endometrial cancer cells by inducing cell cycle arrest	9
Differential expression of PD‑L1 and PD‑L2 is associated with the tumor microenvironment of TILs and M2 TAMs and tumor differentiation in non‑small cell lung cancer	9
Novel EGFR‑bispecific recombinant immunotoxin based on cucurmosin shows potent anti‑tumor efficiency in vitro	9
Potentially life‑threatening severe cutaneous adverse reactions associated with tyrosine kinase inhibitors (Review)	9
Knockdown of PNO1 inhibits esophageal cancer progression	9
GLI2 but not GLI1/GLI3 plays a central role in the induction of malignant phenotype of gallbladder cancer	9
Role of hsa‑miR‑105 during the pathogenesis of paclitaxel resistance and its clinical implication in ovarian cancer	9
Expression of chondroitin sulfate proteoglycan 4 (CSPG4) in melanoma cells is downregulated upon inhibition of BRAF	9
GSG2 knockdown suppresses cholangiocarcinoma progression by regulating cell proliferation, apoptosis and migration	9
Anticancer effects and mechanisms of astragaloside‑IV (Review)	9
Uncovering the interplay between pH receptors and immune cells: Potential drug targets (Review)	9
CDCA5 promotes the progression of breast cancer and serves as a potential prognostic biomarker	9
Effect of claudin 1 on cell proliferation, migration and apoptosis in human cervical squamous cell carcinoma	8
TRIP13 overexpression promotes gefitinib resistance in non‑small cell lung cancer via regulating autophagy and phosphorylation of the EGFR signaling pathway	8
Downregulation of matriptase suppresses the PAR‑2/PLCγ2/PKC‑mediated invasion and migration abilities of MCF‑7 breast cancer cells	8
Interaction between CD9 and PI3K‑p85 activates the PI3K/AKT signaling pathway in B‑lineage acute lymphoblastic leukemia	8
Nuclear IGF1R interacts with NuMA and regulates 53BP1‑dependent DNA double‑strand break repair in colorectal cancer	8
Detecting liquid remnants of solid tumors treated with curative intent: Circulating tumor DNA as a biomarker of minimal residual disease (Review)	8
Icariin inhibits the malignant progression of lung cancer by affecting the PI3K/Akt pathway through the miR‑205‑5p/PTEN axis	8
Inhibition of triple‑negative breast cancer proliferation and motility by reactivating p53 and inhibiting overactivated Akt	8
Radiation exposure triggers the malignancy of non‑small cell lung cancer cells through the activation of visfatin/Snail signaling	8
miR‑497/MIR497HG inhibits glioma cell proliferation by targeting CCNE1 and the miR‑588/TUSC1 axis	8
SLC7A5 is linked to increased expression of genes related to proliferation and hypoxia in estrogen‑receptor‑positive breast cancer	8
Nucleolar and spindle‑associated protein 1 promotes non‑small cell lung cancer progression and serves as an effector of myocyte enhancer factor 2D	8
Emerging histological and serological biomarkers in oral squamous cell carcinoma: Applications in diagnosis, prognosis evaluation and personalized therapeutics (Review)	8